NEOGEN2,388.00

NEOGEN CHEMICALS LTD.

· Chemicals
₹ CrorePeersTATACHEMAETHERNFLLXCHEMPRIVISCLRAINRALLISRCFMcap ₹6,300 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth+12.6+10.9
EBITDA Growth+23.9+0.9
EBIT Growth+24.5+1.4
Net Income Growth-2.3-17.5
EPS Growth-5.4-17.4
Total Assets Growth+19.6+66.1
Total Equity Growth+3.8+3.4
Cash from Operations Growth+772.3-218.1
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.